INFLUENCE OF BOLUS VOLUME AND DOSE OF GADOLINIUM CHELATE FOR FIRST-PASS MYOCARDIAL PERFUSION MR-IMAGING STUDIES

被引:52
作者
CANET, E [1 ]
DOUEK, P [1 ]
JANIER, M [1 ]
BENDID, K [1 ]
AMAYA, J [1 ]
MILLET, P [1 ]
REVEL, D [1 ]
机构
[1] PROF M AMIEL HOP CARDIOVASC & PNEUMOL,SERV RADIOL,LYON,FRANCE
来源
JMRI-JOURNAL OF MAGNETIC RESONANCE IMAGING | 1995年 / 5卷 / 04期
关键词
MYOCARDIUM PERFUSION; CONTRAST MEDIA; CURVE MODELING; MR CONTRAST ENHANCEMENT; MYOCARDIAL ISCHEMIA;
D O I
10.1002/jmri.1880050407
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
First-pass MR myocardial perfusion measurements require a well-defined left ventricular (LV) blood pool input function. We used a peripheral intravenous (IV) injection of a gadolinium (Gd) chelate to obtain a well-characterized LV time-intensity curve. Using a strongly T1-weighted subsecond MR sequence, we performed cardiac MR imaging after administering an IV bolus injection of one of three different doses of the Gd chelate: a standard dose (0.1 mmol/kg, group I, n = 8); a low dose with two bolus volumes (0.01 mmol/kg, 1/10e bolus volume, group II, a = 7, and 0.01 mmol/kg diluted in saline, same bolus volume as group I, group III, n = 3); and an intermediate dose (0.05 mmol/kg, group IV, n = 5). Unlike in group I (high dose), in groups II and III (low dose), the LV curve had a well-defined first peak, followed by a downslope and a recirculation peak. With the intermediate dose (group IV), a saturation effect still remained on the LV curve. The signal intensity (SI) enhancement of the myocardium was respectively 580 +/- 77% at 0.1 mmol/kg, 362 +/- 95% at 0.05 mmol/kg, and at 0.01 mmol/kg, it was 184 +/- 33% in group II and 272 +/- 8% in group III. In conclusion, with subsecond T1-weighted M imaging and a low dose of Gd chelate (i.e., 0.01 mmol/kg), the LV input function is a well-defined first step for MR perfusion modeling.
引用
收藏
页码:411 / 415
页数:5
相关论文
共 17 条
  • [1] Atklnson DJ, Burstein D, Edelman RR, First pass cardiac perfusion: evaluatlon with ultrafast MR Imaghg, Radiology, 174, pp. 757-762, (1990)
  • [2] Manning WJ, Atkinson DJ, Grossman W, Paulln S, Edelman RR, First pass nuclear magnetic resonance imaging studles using gadolinium‐DTPA in patients with coronary artery diseases, J Am Coll Cardiol, 18, pp. 959-965, (1991)
  • [3] Wendland MF, Saeed M, Masui T, Derugin N, Moseley ME, Higglns CB, Echo‐planar MR Imaging of normal and ischemlc myocardium with Gadodiamide injection, Radiology, 186, pp. 535-542, (1993)
  • [4] Welsskoff RM, Chesler D, Boxerman JL, Rosen BR, Pitfalls in MR measurement of tissue blood flow with intravascular tracers: Which mean transit time?, Magnetic Resonance in Medicine, 29, pp. 553-559, (1993)
  • [5] Wilke N, Simm C, Zhang J, Et al., Contrast‐enhanced first pass myocardial perfuslon imaging: correlation between myocardial blood flow in dogs at rest and during hyperemla, Magn Reson Med, 29, pp. 485-497, (1993)
  • [6] Van Rossum AC, Keijer T, Hofman M, Et al., First‐pass MRI of myocardial perfuslon at rest and after pharmacologically Induced vasodilatation in patients with coronary artery disease (abstr), Proceedings of the Society of Magnetic Resonance in Medicine 1993, (1993)
  • [7] Amaya J, Janier MF, Douek PC, Et al., Dipyridamole ultrafast magnetic resonance stress Imaging: detection of severe coronary stenoses (abstr), Circulation, 8, 4, (1993)
  • [8] Manning WJ, Atkinson DJ, Parker JA, Edelman RR, Assessment of intracardiac shunts with gadolinium‐enhanced ultra‐fast MR imaging, Radiology, 184, pp. 351-361, (1992)
  • [9] Gould RG, Lipton MJ, McNamara MT, Sievers RE, Koshold S, Higglns CB, Measurement of regional myocardial blood flow in dogs by ultrafast CT, Invest Radiol, 23, pp. 348-353, (1988)
  • [10] Tong CY, Prato FS, Wisenberg G, Et al., Techniques for the measurement of the local myocardial extraction efficiency for inert diffusible contrast agents such as gadopentate dimeglumine, Magn Reson Med, 30, pp. 332-336, (1993)